SCHEMBL16410708

SCHEMBL16410708

N=CC(C=N)(C=N)c1ccc(CNNC2=Nc3ccccc3NC23CCOCC3)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410775 0.83 — —
SCHEMBL16410735 0.83 — —
SCHEMBL16410605 0.79 ACAT2 (0.32) —
SCHEMBL16410622 0.79 KMT2A (0.37) —
SCHEMBL16410742 0.78 CA12 (0.33) —
SCHEMBL17758044 0.78 EPHX2 (0.38) —
SCHEMBL17758083 0.78 LMNA (0.35) —
SCHEMBL16410739 0.78 KMT2A (0.39) —
SCHEMBL16410722 0.76 OGA (0.32) —
SCHEMBL16410827 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback